High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis

BACKGROUND: Migraine and depression are highly prevalent and partly overlapping disorders that cause strong limitations in daily life. Patients tend to respond poorly to the therapies available for these diseases. OnabotulinumtoxinA has been proven to be an effective treatment for both migraine and...

Descripción completa

Detalles Bibliográficos
Autores principales: Affatato, Oreste, Moulin, Thiago C., Pisanu, Claudia, Babasieva, Victoria S., Russo, Marco, Aydinlar, Elif I., Torelli, Paola, Chubarev, Vladimir N., Tarasov, Vadim V., Schiöth, Helgi B., Mwinyi, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011097/
https://www.ncbi.nlm.nih.gov/pubmed/33789668
http://dx.doi.org/10.1186/s12967-021-02801-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011097/
https://www.ncbi.nlm.nih.gov/pubmed/33789668
http://dx.doi.org/10.1186/s12967-021-02801-w

Ejemplares similares